68 results
Page 2 of 4
8-K
EX-1.1
7uyijjh9i06 1oxe9gse
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
S-8
EX-5.1
tj2 2hxyuo3g84de0
21 Oct 19
Registration of securities for employees
4:26pm
8-K
EX-3.1
uau694phvt0g6lqvi
20 Jun 19
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
4:30pm
8-K
EX-3.1
fllthwp9i 77t4p6i32
8 May 19
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
EX-10.1
ovo7l
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
8-K
EX-10.2
il5g4ja5oximk4 75j
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
S-3/A
EX-4.1
6aq5w bilcxugse3
13 Feb 19
Shelf registration (amended)
9:20am
S-3/A
EX-4.2
dr72u2g5s7x535edhe
13 Feb 19
Shelf registration (amended)
9:20am